Published in Clin Exp Immunol on May 01, 1970
Lymphocyte reactivity contributes to protection conferred by specific antibody passively transferred to herpes simplex virus-infected mice. Infect Immun (1980) 1.32
Resistance of C58 mice to primary systemic herpes simplex virus infection: macrophage dependence and T-cell independence. Infect Immun (1979) 0.93
In vitro spleen leucocyte migration and phytohaemagglutinin-stimulated lymphocyte transformation of immunosuppressed mice cells. I. Cells from mice treated by thymectomy and/or rabbit anti-mouse lymphocyte serum. Clin Exp Immunol (1974) 0.81
Quantitative study of the granulopectic activity of the reticulo-endothelial system. II. A study of the kinetics of the R. E. S. in relation to the dose of carbon injected; relationship between the weight of the organs and their activity. Br J Exp Pathol (1953) 10.45
Studies on heterologous anti-lymphocyte serum in mice. I. In vitro and in vivo properties. J Immunol (1966) 5.59
Cell to cell interaction in the immune response. IV. Site of action of antilymphocyte globulin. J Exp Med (1968) 3.16
The use of immunologically competent cells in the treatment of cancer: experiments with a transplantable mouse tumour. Br J Cancer (1962) 3.10
Changes in the life-span of circulating small lymphocytes in mice after treatment with anti-lymphocyte globulin. Lancet (1968) 2.21
Activity of lymphoid tissues from antilymphocyte-serum-treated mice. Lancet (1967) 1.66
Effects of heterologous anti-lymphocyte serum on the distribution of 51-Cr-labelled lymph node cells in mice. Immunology (1968) 1.52
A study of the effects of anti-macrophage sera. Immunology (1969) 1.44
Reticuloendothelial blockade produced by antilymphocyte serum. Lancet (1969) 1.20
Antilymphocyte serum and the reticuloendothelial system. Lancet (1969) 1.00
IMMUNOLOGICAL MODIFICATIONS OF GRAFT-VERSUS-HOST REACTION. Guys Hosp Rep (1963) 0.88
Modification of the graft-versus-host syndrome by anti-lymphocyte serum treatment of the host. Clin Exp Immunol (1968) 0.86
Studies on heterologous antilymphocyte and antithymocyte sera. 3. Differential effects of rabbit anti-mouse sera on splenic lymphocytes and macrophages. J Immunol (1969) 0.82
Inhibition of circulating lymphocytes by antilymphocytic serum. Br J Surg (1968) 0.82
Reticuloendothelial blockade and A.L.S. Lancet (1969) 0.80
Effects of antilymphocyte sera on antibody forming cells and macrophages in the early immune response. Transplant Proc (1969) 0.79
Inhibitory effect of injection of Corynebacterium parvum on the growth of tumour transplants in isogenic hosts. Br J Cancer (1966) 4.85
Pathways in the development of liver macrophages: alternative precursors contained in populations of lymphocytes and bone-marrow cells. Proc R Soc Lond B Biol Sci (1968) 3.00
Activity of lymphoid tissues from antilymphocyte-serum-treated mice. Lancet (1967) 1.66
The carrier effect in the secondary response to hapten-protein conjugates. 3. The anatomical distribution of helper cells and antibody-forming-cell-precursors. Eur J Immunol (1971) 1.03
Immunological tolerance and inhibition by hapten. Antibiot Chemother (1969) 1.00
Peritoneal and alveolar macrophages derived from lymphocyte populations during graft-versus-host reaction. Br J Exp Pathol (1969) 0.99
A study of technetium-labelled sulphide colloid uptake by regional lymph nodes draining a tumour-bearing area. Br J Surg (1978) 0.89
Modification of the graft-versus-host syndrome by anti-lymphocyte serum treatment of the donor. Clin Exp Immunol (1968) 0.87
Modification of the graft-versus-host syndrome by anti-lymphocyte serum treatment of the host. Clin Exp Immunol (1968) 0.86
Inhibition of circulating lymphocytes by antilymphocytic serum. Br J Surg (1968) 0.82
In vitro spleen leucocyte migration and phytohaemagglutinin-stimulated lymphocyte transformation of immunosuppressed mice cells. I. Cells from mice treated by thymectomy and/or rabbit anti-mouse lymphocyte serum. Clin Exp Immunol (1974) 0.81
Stimulation of lymphocytes by direct exposure to antigen in vitro. Transplant Proc (1969) 0.80
Local Corynebacterium parvum therapy in early breast cancer: a pilot study. Clin Oncol (1978) 0.79
Changing in vitro leucocyte migration and transformation responses in renal allograft recipients. Transplantation (1973) 0.79
Clinical experience in the use of C. parvum in the treatment of locally advanced carcinoma of the breast. Dev Biol Stand (1978) 0.78
The effect of intravenous infusion of Corynebacterium parvum on an immune profile of women with breast cancer. Dev Biol Stand (1978) 0.78
The effect of Corynebacterium parvum on the proliferation of monocyte precursors in the bone marrow of mice. Dev Biol Stand (1978) 0.77
Spleen size in women with breast cancer. Clin Oncol (1979) 0.77
Tumour histology and spleen size in women with breast cancer. Clin Oncol (1980) 0.76
In vitro spleen leucocyte migration and phytohaemagglutinin-stimulated lymphocyte transformation of immunosuppressed mice cells. II. Cells from mice treated by azathioprine and/or immune stimulation or thymectomy. Clin Exp Immunol (1974) 0.75
An in vitro study of renal allograft recipients for cellular delayed type hypersensitivity to glomerular basement membrane and disrupted spleen cells. Clin Exp Immunol (1972) 0.75
Human thoracic duct drainage. Br J Surg (1970) 0.75
The effect of antilymphocyte serum (ALS) on phagocytic activity in mice. Br J Surg (1969) 0.75
Origin of hepatic, alveolar, and peritoneal macrophages. Br J Surg (1969) 0.75
Assay of antilymphocyte serum by inhibition of circulating lymphocyte activity. Br J Surg (1969) 0.75
Direct stimulation of lymphocytes by antigen in vitro. Br J Surg (1968) 0.75
A horse anti-human lymphocytic serum for clinical trial in renal homo-transplantation. Br J Surg (1969) 0.75
Diagnosis of malignant breast disease by axillary lymphoscintigraphy: a preliminary report. Br J Surg (1978) 0.75
Host responses to methylcholanthrene sarcoma and sheep red blood cell skeletal implants. Clin Oncol (1977) 0.75
Proceedings: The effect of oestrogen on the proliferation of monocyte/macrophage precursors in the bone marrow of mice. Br J Surg (1976) 0.75
Transplantation of second cadaver donor kidneys. Br J Surg (1969) 0.75
Management of toxic megacolon. Br J Clin Pract (1982) 0.75
The thymic influence on immunological recovery from antilymphocytic serum therapy. Br J Surg (1970) 0.75
The role of axillary lymphoscintigraphy in the diagnosis of breast cancer. Clin Oncol (1981) 0.75
Proceedings: Local Corynebacterium parvum therapy in early breast cancer. Br J Surg (1976) 0.75
The management of the patient with catecholamine excess. World J Surg (1982) 0.75
Macrophage migration and lymphocyte transformation studies on peripheral blood-cells from human renal allograft recipients. Br J Surg (1971) 0.75
High bile duct strictures. Br J Surg (1980) 0.75
T and B lymphocytes in breast cancer. Lancet (1977) 0.75
DNA and RNA measurements on thoracic duct lymphocytes of patients undergoing renal transplantation. Transplantation (1970) 0.75
Modification of the second set reaction by antilymphocytic serum. Br J Surg (1971) 0.75
Effect of Corynebacterium parvum on subcutaneous and skeletal methylcholanthrene sarcoma implants. Clin Oncol (1977) 0.75